AGP Picks
View all

AGP Executive Report

Last update: 9 hours ago

Work and Wellbeing: A study of more than 5,600 people in the Northern Finland Birth Cohort found evening types had a higher risk of disability pension than morning types. The link weakened after accounting for health and work schedules, and the study cannot show cause and effect. Flu Vaccinations: Delayed vaccine deliveries have pushed Helsinki’s maternity and child-clinic vaccinations to 16 November for pregnant people and children aged six months to two years. Vaccination weeks have also moved to 16–27 November. Care in Helsinki: The city is piloting an AI tool to help document health and social-services work, while patients have reported long overnight waits in emergency departments. Cancer Care: Finnish reporting says delays in cancer treatment are linked to poorer outcomes than in other Nordic countries; a separate Finnish study found poor oral health raises the risk of jawbone necrosis in breast cancer patients. Family Support: A study comparing Finnish municipal data found stronger reported social support and more contact beyond the household were associated with higher fertility rates. It does not show that social connections cause people to have children.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Aug. 28, 2026

NOA Villas says sleep is becoming a luxury draw in Finnish Lapland

AGP

fallback image
Jul. 30, 2026

SGS Finland gains EU Battery Regulation Notified Body status

AGP

fallback image
Jul. 20, 2026

AMT Medical’s sutureless bypass system posts 1-year safety data

AGP

fallback image
Jul. 16, 2026

RAPIDÈ opens Singapore's first clinician-led recovery atelier

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Clinical Outcomes of High-Flow Nasal Cannula Combined with Standardized Acupoint Application in Acute Exacerbations of COPD: A Retrospective Study

Clinical Outcomes of High-Flow Nasal Cannula Combined with Standardized Acupoint Application in Acute Exacerbations of COPD: A Retrospective Study

Supply shortage delays influenza vaccination at Helsinki maternity, child health clinics

Supply shortage delays influenza vaccination at Helsinki maternity, child health clinics

Patient Awareness, Willingness, and Barriers to Pharmacist-Managed Clinics in a Chinese Tertiary Hospital: A Cross-Sectional Survey

Patient Awareness, Willingness, and Barriers to Pharmacist-Managed Clinics in a Chinese Tertiary Hospital: A Cross-Sectional Survey

Creatinine Clearance, Ceftazidime-Avibactam Exposure, and Clinical Outcomes in a Real-World TDM Cohort: A Retrospective Observational Study

Creatinine Clearance, Ceftazidime-Avibactam Exposure, and Clinical Outcomes in a Real-World TDM Cohort: A Retrospective Observational Study

Metabolic, Atherogenic, and Anthropometric Markers for Discrimination of Premature Coronary Artery Disease in a Predominantly Statin-Treated Cohort

Metabolic, Atherogenic, and Anthropometric Markers for Discrimination of Premature Coronary Artery Disease in a Predominantly Statin-Treated Cohort


fallback image
Oct. 15, 2026

EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe

GlobeNewswire, Inc.

fallback image
Oct. 16, 2026

Optivian expands into UK and Ireland with sales team in London and Dublin

EIN Presswire

fallback image
Oct. 7, 2026

Nouryon cleared by regulators to supply a plant-based, water-soluble pharmaceutical ingredient in China's expanding drug manufacturing market

GlobeNewswire, Inc.

fallback image
Oct. 5, 2026

Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing

GlobeNewswire, Inc.

fallback image
Sep. 24, 2026

AMSA and ŌURA Collaborate to Make Innovation Fest 2026 the Best Student-Led Health Tech Event Yet

EIN Presswire

fallback image
Sep. 24, 2026

Kasvu Therapeutics Raises €30 Million Series A Financing Round led by Hadean Ventures to Advance its Novel TrkB Potentiator into Clinical Development Targeting Neuropsychiatric Disorders

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Can the EU Step up Where the US is Stepping Back?
Play
Can the EU Step up Where the US is Stepping Back?
YouTube video thumbnail:  EU Member States set for Budget Clash
Play
EU Member States set for Budget Clash
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: How ASML Have Become a European AI Industry Darling
Play
How ASML Have Become a European AI Industry Darling
YouTube video thumbnail: Inside Albania's Protest Movement: What's Fanning the Flames?
Play
Inside Albania's Protest Movement: What's Fanning the Flames?

Video Title

Sign up for:

Health Daily Finland

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Daily Finland

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.